Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1953 1
1954 2
1955 1
1956 2
1962 2
1963 9
1964 5
1965 1
1966 2
1967 8
1968 10
1969 12
1970 12
1971 24
1972 17
1973 10
1974 9
1975 11
1976 15
1977 15
1978 17
1979 17
1980 13
1981 22
1982 14
1983 15
1984 18
1985 16
1986 18
1987 18
1988 18
1989 17
1990 12
1991 10
1992 11
1993 11
1994 13
1995 12
1996 9
1997 13
1998 18
1999 27
2000 39
2001 26
2002 24
2003 28
2004 21
2005 18
2006 19
2007 28
2008 37
2009 29
2010 32
2011 44
2012 35
2013 41
2014 39
2015 33
2016 35
2017 39
2018 41
2019 51
2020 49
2021 62
2022 28
Text availability
Article attribute
Article type
Publication date

Search Results

1,220 results
Results by year
Filters applied: . Clear all
Page 1
[The Adverse Effects of Ephedra Herb and the Safety of Ephedrine Alkaloids-free Ephedra Herb Extract (EFE)].
Odaguchi H, Hyuga S, Sekine M, Nakamori S, Takemoto H, Huang X, Oshima N, Shimada N, Yang J, Amakura Y, Hyuga M, Uchiyama N, Kobayashi Y, Hakamatsuka T, Goda Y, Hanawa T. Odaguchi H, et al. Among authors: shimada n. Yakugaku Zasshi. 2019;139(11):1417-1425. doi: 10.1248/yakushi.19-00122. Yakugaku Zasshi. 2019. PMID: 31685738 Free article. Review. Japanese.
C1'-Azacycloalkyl Hexahydrocannabinols.
Ho TC, Shimada N, Tius MA, Nikas SP, Zhang W, Makriyannis A. Ho TC, et al. Among authors: shimada n. J Org Chem. 2017 Aug 4;82(15):7839-7849. doi: 10.1021/acs.joc.7b00988. Epub 2017 Jul 17. J Org Chem. 2017. PMID: 28677397
[Report in 2018 April ~ 2020 March].
Tateishi U, Matsumoto K, Daisaki H, Suzuki K, Shimada N, Akamatsu G. Tateishi U, et al. Among authors: shimada n. Kaku Igaku. 2021;58(1):15-17. doi: 10.18893/kakuigaku.wgr.2133. Kaku Igaku. 2021. PMID: 33612570 Free article. Japanese.
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC-B stage patients classified as beyond up to seven criteria - Multicenter analysis.
Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (Hepatocellular Carcinoma Experts from 48 Clinics in Japan. Hiraoka A, et al. Among authors: shimada n. Hepatol Res. 2022 Mar;52(3):308-316. doi: 10.1111/hepr.13734. Epub 2021 Dec 2. Hepatol Res. 2022. PMID: 34799975
Cationic copolymer-chaperoned short-armed 10-23 DNAzymes.
Hanpanich O, Miyaguchi H, Huang H, Shimada N, Maruyama A. Hanpanich O, et al. Among authors: shimada n. Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):156-169. doi: 10.1080/15257770.2019.1675168. Epub 2019 Oct 12. Nucleosides Nucleotides Nucleic Acids. 2020. PMID: 31608816
1,220 results